chartexchange

Curis Inc (CRIS) (Q3 2026) Earnings Call Highlights: Strong PCNSL Response Rates and CLL ...

GuruFocus | Nov 13, 2026 12:05 AM EST

Curis Inc (CRIS) reported an 86% response rate in BTK-naive PCNSL patients and advancing CLL proof-of-concept data, while managing a $8.1 million quarterly net loss and relying on October financing… Related Stocks: CRIS ,

Read original article